Coram is a preferred provider of Aralast™ (manufactured by Baxter Healthcare) and Zemaira^® (manufactured by CSL Behring), the latest therapies to treat antitrypsin deficiency (Alpha-1). Alpha-1 is a hereditary form of progressive emphysema. Alpha-1 patients have traditionally had to worry about when their medication would arrive and whether their supply would be sufficient. Not anymore.

Coram has years of experience caring for and treating alpha-1 patients. Coram also offers one of the nation's leading organ transplant home care programs and has treated thousands of lung transplant patients since its inception. Moreoever, as an Apria Healthcare Company, Coram is the only company to offer alpha-1 patients access to oxygen, related respiratory medications and home medical equipment.

In addition to caring for diagnosed alpha-1 patients and offering an extensive patient advocacy program, Coram takes an active role in promoting testing for this disease, which is severely under diagnosed. Since the disease is progressive, the earlier the diagnosis, the better the patient's chances for a positive outcome.

To learn more about Coram's Alpha-1 Therapy services, contact us. To enroll or refer a patient to Coram, click here.